A new study found a nationwide effort to control carbapenem-resistant Enterobacteriaceae (CRE) in Israel reduced CRE cases by improving compliance of infection control standards and using a coordinated intervention focused on long-term care facilities. The study was published in the July issue of Infection Control and Hospital Epidemiology.
“As the global threat of CRE continues to rise, there is a need to better control and understand this bacteria,” says Debby Ben-David, MD, a lead author of the study. “Broadening our focus to long-term care facilities made an impact and reduced the prevalence of these infections, demonstrating the need to look beyond acute care hospitals in our infection control interventions.”
Since 2006, Israel faced a nationwide outbreak of CRE throughout its healthcare system. A 2008 cross-sectional prevalence survey conducted in Israeli post-acute care hospitals (PACHs), similar to long term acute care hospitals in the U.S., revealed a high prevalence of CRE carriage in PACH patients. The transfer of colonized patients between acute care hospitals to PACHs and back again fosters the spread of these drug-resistant infections in healthcare institutions. Based on these results, the Israeli National Center for Infection Control (NCIC) initiated a multifaceted intervention in all PACHs, as part of a national program involving all healthcare facilities in the country.
The intervention included: 1) on-site assessments of infection control policies and practices; 2) CRE isolation guidelines targeted to long-term care facilities; 3) mandatory census reporting of CRE carriers sent to NCIC to facilitate monitoring, compliance with guidelines and track infected patient movement into and out of these facilities; and 4) follow-up surveys of CRE carriage in patients to assess the impact of the intervention on carrier prevalence.
The four-year prospective cohort interventional study found a direct correlation between hospitals with a high infection control scores from the on-site assessment and a lower risk of newly discovered CRE carriage. Healthcare facilities’ compliance with infection control practices, as measured through onsite assessments, increased more than twofold (score of 6.8 to 14.2 out of 16) and the overall carrier prevalence decreased by approximately 25 percent.
The intervention, carried out in the context of a nationwide initiative to contain CRE spread in healthcare facilities, was based on an understanding of the importance of centrally coordinated regional intervention to contain the spread of multidrug-resistant organisms.
Reference: Debby Ben-David, Samira Masarwa, Amos Adler, Hagit Mishali, Yehuda Carmeli, Mitchell J. Schwaber. A National Intervention to Prevent the Spread of Carbapenem-Resistant Enterobacteriaceae in Israeli Post-Acute Care Hospitals. Infection Control and Hospital Epidemiology [35:7] (July 2014).
Source: Society for Healthcare Epidemiology of America (SHEA)
From Shortages to Security: How Reusable Health Care Textiles Can Transform Infection Prevention
March 7th 2025Reusable health care textiles enhance infection prevention, reduce waste, and strengthen supply chains. Hygienically clean textiles offer a sustainable, cost-effective alternative to disposable PPE, ensuring patient safety and environmental responsibility.
Prove Your Expertise: The Value of AL-CIP Certification in Infection Prevention
February 24th 2025The Advanced Leadership Certification in Infection Prevention (AL-CIP) validates leadership, expertise, and strategic decision-making in infection control. Learn why top professionals pursue this certification and how it enhances careers, and apply for yours today!
Infection Intel: GermZapp Is the Innovative Hand Hygiene System IPC Needs
February 14th 2025GermZAPP is an affordable hand hygiene system designed to educate, monitor, and encourage adherence in schools, nursing homes, and health care settings, effectively addressing gaps in infection control.
Fungal Infections: The Silent Epidemic Threatening Global Health
February 6th 2025Fungal infections are a rising global threat, with antifungal resistance complicating treatment. Neil J. Clancy, MD, emphasizes the urgent need for research, better diagnostics, and stronger infection prevention strategies.